TSXV/IDL (TSXV/IDL)

TSX Venture Exchange: TSXV/IDL · CAD

CA$0.10

+0.00 (0.0%)· Recorded snapshot

Market cap	1M
Revenue (ttm)	39.9K
Net income (ttm)	-1.1M
EPS (ttm)	-CA$0.11
Shares out	10.3M
Volume	0
Beta	1.92

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 39.9K
Net income (ttm): -1.1M
EPS (ttm): -CA$0.11
Market cap: 1M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 11P50 16.8P75 23.9

Trailing P/En/a

P25 9.9P50 23.3P75 38.5

ROEn/a

P25 -104.1P50 -30P75 6.7

ROICn/a

P25 -55.9P50 -12.1P75 5

Benchmarks · 1M

All TSXV/IDL indicators

Market & fundamental data

Available fields

158

Groups with data

Currency

CAD

Showing 158 of 158 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-27
Employees	89
Enterprise value	CAD 6.6M
Exchange	TSX Venture Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1995
Industry	Medical Devices
Is primary listing	Yes
ISIN number	CA4519205088
Last earnings date	2025-11-27
Last refreshed	2026-10-29
Last stock split date	2021-11-02
Last stock split type	Reverse
Market cap	CAD 1M
Next earnings date	2026-11-27
Price	CAD 0.10
Price currency	CAD
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-20
Symbol	tsxv/IDL
Website	https://www.imagingdynamics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-109.01%
EV/Sales	165.23x
FCF / EV yield	-8.21%
FCF yield	-52.4%
P/S ratio	25.88x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	172.07%
Operating margin	-1,489.44%
Pretax margin	-2,821.43%
Profit per employee	CAD -12,658
Revenue per employee	CAD 449
ROA	-191.95%
ROA (5Y)	-130.35%
ROCE	9.33%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Gross profit growth	-1.24%
Gross profit growth (Q)	-52.91%
Gross profit growth 3Y	-22.55%
Gross profit growth 5Y	-25.77%
Revenue growth	-65.1%
Revenue growth (Q)	-64.51%
Revenue growth (QoQ)	263.91%
Revenue growth 10Y	-35.53%
Revenue growth 3Y	-41.24%
Revenue growth 5Y	-37.94%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -1,100
Depreciation and amortization	CAD -5,941
EBIT	CAD -594,732
EBITDA	CAD -600,673
EPS	CAD -0.11
FCF per share	CAD -0.05
Financing cash flow	CAD 523,574
Free cash flow	CAD -541,580
Gross profit	CAD 68,707
Investing cash flow	CAD -9,876
Net borrowing	CAD 523,574
Net cash flow	CAD -26,782
Net income	CAD -1.1M
Operating income	CAD -594,732
Revenue	CAD 39,930

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-654.18
Book value per share	CAD -0.63
Interest coverage	-2.06
Long-term assets	CAD 210,270
Long-term liabilities	CAD 160,303
Net cash (debt)	CAD -5.6M
Net cash / market cap	-538.4%
Piotroski F-Score	2
Property, plant and equipment	CAD 210,270
Shareholders' equity	CAD -6.5M
Tangible book value	CAD -6.5M
Tangible book value per share	CAD -0.63
Total assets	CAD 268,277
Total cash	CAD 11,947
Total debt	CAD 5.6M
Total liabilities	CAD 6.8M
WACC	5.78%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.21
Current assets	CAD 58,007
Current liabilities	CAD 6.6M
Current ratio	0.01
Net working capital	CAD -1.2M
Quick ratio	0
Working capital	CAD -6.6M
Working capital turnover	-0.01

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-97.62%
10Y return CAGR	-31.19%
10Y total return	-97.62%
150-day SMA	CAD 0.89
15Y price change	-98.67%
15Y return CAGR	-25.01%
15Y total return	-98.67%
1D price change	0%
1M price change	81.82%
1M total return	81.82%
1W price change	81.82%
1W total return	81.82%
1Y price change	233.33%
1Y return CAGR	233.61%
1Y total return	233.33%
20-day SMA	CAD 0.05
200-day SMA	CAD 0.91
20Y price change	-99.99%
20Y return CAGR	-37.49%
20Y total return	-99.99%
3M price change	100%
3M total return	100%
3Y price change	-9.09%
3Y return CAGR	-3.13%
3Y total return	-9.09%
50-day SMA	CAD 0.10
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.10
52-week high date	2026-10-20
52-week low	CAD 0.04
52-week low date	2026-03-25
6M price change	100%
6M total return	100%
All-time high	CAD 10,875.00
All-time high date	2000-03-15
All-time low	CAD 0.02
All-time low date	2024-10-24
Average true range (ATR)	CAD 0.02
Average volume	7.7K
Beta (1Y)	0.55
Beta (2Y)	0.39
Beta (5Y)	1.92
Change from 52-week high	0%
Change from 52-week low	185.71%
Change from all-time high	-100%
Change from all-time low	400%
Monthly RSI	47.82
Previous close	CAD 0.10
Price vs 150-day SMA	-88.7%
Price vs 20-day SMA	98.81%
Price vs 200-day SMA	-89%
Price vs 50-day SMA	-4.31%
Relative volume	0.26
RSI	53.36
Sharpe ratio	1.71
Sharpe ratio (3Y)	1.2
Sharpe ratio (5Y)	1.24
Sortino ratio	6.39
Sortino ratio (3Y)	3.72
Sortino ratio (5Y)	3.33
Volume	0
Weekly RSI	41.62
YTD price change	150%
YTD total return	150%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares change (QoQ)	0%
Shares outstanding	10.3M
Short ratio	0.6 days

Deeper analysis on TSXV/IDL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSXV/IDL report

Is a complete TSXV/IDL research report available?

No complete published report is available for tsxv/IDL (TSXV/IDL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSXV/IDL (TSXV/IDL)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/IDL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/IDL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Performance and technicals

Ownership and float

Deeper analysis on TSXV/IDL

Frequently asked questions